Search

everythinglearnresearchcommunity

for

Search:↓

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

New treatments for hair loss show promise, but require more research on long-term effects and proper dosing.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Adenosine may promote hair growth by increasing FGF-7 levels in dermal papilla cells.

Tofacitinib is an effective and safe treatment for alopecia areata.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

GI197111X is best dissolved in Capmul MCM for trials.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

AIMP1 can boost hair growth by increasing stem cell activity.